Literature DB >> 15247350

HIV and AIDS in the Former Soviet Bloc.

Mark G Field1.   

Abstract

Entities:  

Mesh:

Year:  2004        PMID: 15247350     DOI: 10.1056/NEJMp048066

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  The feasibility of HIV vaccine efficacy trials among Russian injection drug users.

Authors:  Chris Beyrer; Stefan Baral; Alla Shaboltas; Elena Dukhovlinova; Alexey Masharsky; Sergey Verevochkin; Carl Latkin; Robert Heimer; Irving Hoffman; Andrei Kozlov
Journal:  Vaccine       Date:  2007-08-03       Impact factor: 3.641

2.  Potential bridges of heterosexual HIV transmission from drug users to the general population in St. Petersburg, Russia: is it easy to be a young female?

Authors:  Olga Toussova; Irina Shcherbakova; Galina Volkova; Linda Niccolai; Robert Heimer; Andrei Kozlov
Journal:  J Urban Health       Date:  2009-06-16       Impact factor: 3.671

3.  Risk of syphilis in STI clinic patients: a cross-sectional study of 11,500 cases in Guangxi, China.

Authors:  Susan P Y Wong; Yue-Ping Yin; Xing Gao; Wan-Hui Wei; Mei-Qin Shi; Pei-Yong Huang; Hong Wang; Qiang Chen; Musang Liu; Joseph D Tucker; Xiang-Sheng Chen; Myron S Cohen
Journal:  Sex Transm Infect       Date:  2007-06-25       Impact factor: 3.519

4.  Activism, NGOs, and HIV Prevention in Postsocialist Poland: The Role of "Anti-Politics"

Authors:  Jill Owczarzak
Journal:  Hum Organ       Date:  2010

5.  The Effectiveness of Harm Reduction Programs in Seven Prisons of Iran.

Authors:  Payam Roshanfekr; Marziyeh Farnia; Masoumeh Dejman
Journal:  Iran J Public Health       Date:  2013-12       Impact factor: 1.429

6.  Untreated depression among persons living with human immunodeficiency virus in Kazakhstan: A cross-sectional study.

Authors:  Dina Terloyeva; Zhamilya Nugmanova; Gulzhakhan Akhmetova; Aikan Akanov; Nimish Patel; Victoria Lazariu; Lisa Norelli; Louise-Anne McNutt
Journal:  PLoS One       Date:  2018-03-28       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.